PRICE T ROWE ASSOCIATES INC /MD/ - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 147 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$40
-66.9%
23,952
+2.4%
0.00%
Q1 2024$121
+0.8%
23,380
+12.2%
0.00%
Q4 2023$120
+53.8%
20,835
+28.6%
0.00%
Q3 2023$78
+73.3%
16,198
+53.6%
0.00%
Q2 2023$45
-19.6%
10,5460.0%0.00%
Q1 2023$5610,5460.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 544,196$5,741,00019.52%
Elmwood Wealth Management, Inc. 2,364,240$24,943,00012.45%
72 Investment Holdings, LLC 474,067$5,001,0003.96%
PFM Health Sciences, LP 6,000,000$63,300,0002.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 257,892$2,716,0000.87%
Avidity Partners Management LP 3,172,600$33,471,0000.68%
Rokos Capital Management LLP 1,907,509$20,811,0000.62%
Green Alpha Advisors, LLC 69,376$732,0000.62%
Nelson Capital Management, LLC 85,020$897,0000.26%
Tekla Capital Management LLC 567,147$5,983,0000.24%
View complete list of CARIBOU BIOSCIENCES INC shareholders